Instil Bio, Inc.
TIL· Nasdaq
Released Nov 13, 2025, before the open
10-Q filed Nov 13, 2025, 44 days after period end · 0001789769-25-000094
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Net Income | -$13.59M | -$23.02M | -$67.43M | -$56.22M |
| EPS Diluted | -$2.01 | -$3.54 | -$10.37 | -$0.43 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Instil Bio, Inc. · CIK 1789769 · Engraved from SEC EDGAR